Breaking News Instant updates and real-time market news.

FDC

First Data

$18.25

-0.6 (-3.18%)

, SHPG

Shire

$161.67

1.59 (0.99%)

09:55
09/12/17
09/12
09:55
09/12/17
09:55

First Data, Shire among stocks touted by Cooperman at Delivering Alpha

Leon Cooperman is discussing First Data (FDC), Shire (SHPG) United Continental (UAL), Hess Corp. (HES) and WPX Energy (WPX) as among stocks on which he is positive, according to CNBC, citing the investors appearance at the network's "Delivering Alpha" event. Cooperman has previously disclosed that he holds stakes in all five, CNBC noted.

FDC

First Data

$18.25

-0.6 (-3.18%)

SHPG

Shire

$161.67

1.59 (0.99%)

UAL

United Continental

$60.87

0.41 (0.68%)

HES

Hess Corp.

$41.02

0.1 (0.24%)

WPX

WPX Energy

$9.85

0.06 (0.61%)

  • 12

    Sep

  • 12

    Sep

  • 13

    Sep

  • 13

    Sep

  • 19

    Sep

  • 25

    Sep

  • 27

    Sep

  • 14

    Sep

FDC First Data
$18.25

-0.6 (-3.18%)

07/17/17
RHCO
07/17/17
NO CHANGE
RHCO
Hold
Vantiv should be held amid pricing concerns, says SunTrust
SunTrust analyst Andrew Jeffrey recommends holding shares of Vantiv (VNTV) on any weakness surrounding a negative report highlighting the company's pricing practices. The analyst recommends adding to positions in Global Payments (GPN) and First Data (FDC). Vantiv and its Mercury unit have been aggressive on pricing, but the practices are tied to value-added technology, not an effort to confuse merchants, Jeffrey tells investors in a research note. The analyst also feels the accusations are "impossible to substantiate." He adds that Global Payments and First Data have not pursued pricing practices similar to Vantiv/Mercury. Jeffrey has a Hold rating on Vantiv. The shares are down 3% to $63.21 after Capitol Forum questioned the company's "deceptive" billings practices.
06/28/17
06/28/17
DOWNGRADE

On The Fly: Top five analyst downgrades
Catch up on today's top five analyst downgrades with this list compiled by The Fly: 1. Qualcomm (QCOM) downgraded to Market Perform from Outperform at Northland with analyst Tom Sepenzis citing the previous guidance change due to the dispute with Apple (AAPL) and its suppliers. The analyst is uncertain Qualcomm's model will survive multiple attacks from regulators and now Apple, and said the longer the fight with Apple goes on the more the negative impact on shares will be. 2. Alder Biopharmaceuticals (ALDR) downgraded to Neutral from Outperform at Credit Suisse with analyst Vamil Divan citing the release of data from the PROMISE-1 trial of eptinezumab in frequent migraine treatment. Divan lowered his price target on Alder shares to $17 from $30. 3. Advance Auto Parts (AAP) downgraded to Neutral from Buy at Cleveland Research with the firm saying checks indicate that second quarter comparables are likely running below consensus as industry weakness pressures sales trends. 4. Brookfield Renewable (BEP) downgraded to Neutral from Outperform at Macquarie with analyst David Noseworthy citing expectations that growth in the U.S. will slow after the closing of the TerraForm Power (TERP) and TerraForm Global (GLBL) acquisitions, risk from increasing exposure to developing market, and premium valuation. 5. First Data (FDC) downgraded to Equal Weight from Overweight at Morgan Stanley with analyst James Faucette saying the turnaround in fundamentals is largely reflected in shares and deleveraging potential is less likely to be a driver going forward. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
06/28/17
06/28/17
DOWNGRADE
Target $19

Equal Weight
First Data downgraded to Equal Weight on valuation at Morgan Stanley
As previously reported, Morgan Stanley downgraded First Data (FDC) to Equal Weight and raised its price target to $19 from $18. Analyst James Faucette said the turnaround in fundamentals is largely reflected in shares and said deleveraging potential is less likely to be a driver going forward. The analyst prefers Vantiv (VNTV) following the recent pullback and thinks it will overcome concerns on softness in retail.
08/08/17
CHLM
08/08/17
NO CHANGE
Target $25
CHLM
Buy
First Data price target raised to $25 from $20 at Craig-Hallum
Craig-Hallum analyst Bradley Berning raised his price target for First Data to $25 from $20 following quarterly results and as he sees potential 2018 year over year revenue acceleration to mid-high single digits. The analyst reiterates a Buy rating on the shares.
SHPG Shire
$161.67

1.59 (0.99%)

08/16/17
EVER
08/16/17
INITIATION
Target $196
EVER
Outperform
Shire initiated with an Outperform at Evercore ISI
Evercore ISI analyst Josh Schimmer initiated Shire with an Outperform and a $196 price target.
07/14/17
CANT
07/14/17
NO CHANGE
CANT
Worries about Shire hemophilia franchise overdone, says Cantor
After speaking with a pediatric hematology/oncology physician, Cantor analyst Louise Chen reports that the doctor said that uptake of Roche's (RHHBY) hemophilia treatment, ACE910, "will be gradual" because of safety concerns. The analyst says that worries about Shire's (SHPG_) hemophilia franchise are overdone. She keeps a $222 price target and an Overweight rating on the stock.
07/11/17
COWN
07/11/17
NO CHANGE
Target $325
COWN
Outperform
Shire hemophilia franchise being valued near zero, says Cowen
Cowen analyst Ken Cacciatore believes Shire's (SHPG) current valuation reflects essentially no value for the company's hemophilia franchise. Investors are treating Shire/Baxalta's hemophilia franchise as if it should equate to essentially zero, into perpetuity, beginning in 2020, Cacciatore tells investors in a research note, citing his analysis. He believes this sentiment, based on competitive concerns from Roche (RHHBY) and Alnylam (ALNY), is a "gross overreaction." The analyst has an Outperform rating on Shire with a $325 price target.
08/22/17
JEFF
08/22/17
NO CHANGE
JEFF
Buy
Shire CFO departure timing 'inopportune,' says Jefferies
Jefferies analyst David Steinberg called the "surprising move" of Shire CFO Jeff Poulton out of his current post and into a role at an agriculture biotech start-up "naturally raises some concerns" given the recent departure of the company's head of R&D, adding that the timing is "highly inopportune." However, after speaking with Poulton, the analyst's take is that the move is motivated by an interest in a more entrepreneurial opportunity. Steinberg keeps a Buy rating on Shire shares, which slid 3% yesterday.
UAL United Continental
$60.87

0.41 (0.68%)

07/27/17
RAJA
07/27/17
NO CHANGE
RAJA
Strong Buy
Spirit Airlines selloff overdone on fare weakness comments, says Raymond James
Raymond James analyst Savanthi Syth attributes the selloff in Spirit Airlines (SAVE) shares, and those of other U.S. airline peers, to the company's commentary about fare weakness spreading to a larger number of markets in the last few weeks and signals that the pressure is due to United (UAL) being aggressive with pricing. However, he believes the pullback is overdone, stating that he doesn't believe this is sustainable given United's stated goal to close its margin gap with Delta (DAL). He has a Strong Buy rating on Spirit Airlines shares, which are down nearly 20% in afternoon trading.
08/01/17
JPMS
08/01/17
UPGRADE
Target $45
JPMS
Overweight
Spirit Airlines upgraded to Overweight from Neutral at JPMorgan
JPMorgan analyst Jamie Baker upgraded Spirit Airlines to Overweight while lowering his price target for the shares to $45 from $56. With the recent selloff, the market is ignoring the company's potential for "medium-term course correction on growth and pricing," Baker tells investors in a research note. He believes the United Continental (UAL), Spirit pricing spat "appears less dire" than the market is pricing in.
08/07/17
BERN
08/07/17
NO CHANGE
BERN
American 'most at risk' from United Continental price actions, says Bernstein
Bernstein analyst David Vernon says that American Airlines (AAL) is "most at risk" from United Continental's (UAL) price cuts. The analyst adds that Spirit (SAVE) will have to give its pilots a 60%-80% raise, possibly putting five to six percentage points of its margins at risk. Vernon keeps Market Perform ratings on American and United.
07/12/17
UBSW
07/12/17
NO CHANGE
Target $109
UBSW
Buy
United Continental price target raised to $109 from $103 at UBS
UBS analyst Darryl Genovisi raised his price target on United Continental to $109 from $103 citing its Q2 metrics while also raising his estimates and updating his EBIT margin forecast to reflect a higher second half cargo revenue growth assumption. Genovisi reiterated his Buy rating on United Continental shares.
HES Hess Corp.
$41.02

0.1 (0.24%)

07/17/17
WOLF
07/17/17
DOWNGRADE
WOLF
Peer Perform
Hess Corp. downgraded to Peer Perform from Outperform at Wolfe Research
06/27/17
ATLE
06/27/17
DOWNGRADE
Target $45
ATLE
Neutral
Hess Corp. downgraded to Neutral from Overweight at Atlantic Equities
Atlantic Equities analyst Barry MacCarthy downgraded Hess to Neutral and cut its price target to $45 from $68 saying the development approval for phase 1 of the Liza field was not the positive catalyst he had hoped for despite favorable economics. The analyst thinks Guyanan suffers as a non-shale play, especially with production beyond many investors horizon.
06/21/17
SOCO
06/21/17
DOWNGRADE
SOCO
Underweight
Hess Corp. downgraded to Underweight from Equalweight at Capital One
06/27/17
06/27/17
DOWNGRADE

On The Fly: Top five analyst downgrades
Catch up on today's top five analyst downgrades with this list compiled by The Fly: 1. Impinj (PI) was downgraded to Sector Weight from Overweight by Pacific Crest analyst Brad Erickson based on valuation. 2. Mizuho analyst Haendel St. Juste downgraded Store Capital (STOR) to Neutral from Buy citing fair valuation following recent strength driven by Berkshire Hathaway's (BRK.A) investment. 3. Camtek (CAMT) was downgraded to Hold from Buy by Needham analyst Y. Edwin Mok, as he expects to see some deceleration as the PCB business normalizes and he believes large orders for back-end semi inspections are already reflected in the stock after its recent run-up. 4. Nomura Instinet analyst Dan Dolev downgraded Cintas (CTAS) to Neutral from Buy after lowering his FY18 uniform rental organic growth forecasts to 5% from 7%. 5. Atlantic Equities analyst Barry MacCarthy downgraded Hess Corp. (HES) and Schlumberger (SLB), both to Neutral from Overweight, given his view of the limited prospects for an oil price rebound. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
WPX WPX Energy
$9.85

0.06 (0.61%)

06/21/17
GHSC
06/21/17
DOWNGRADE
GHSC
Sell
WPX Energy downgraded to Sell from Buy at Seaport Global
Seaport Global's Energy team reduced its long-term oil forecast to $40/bbl from $50/bbl to reflect "relentless" US production growth. The firm sees the potential for the oil market to be "significantly over supplied in 2018 and cut its oil price forecast for first half 2017 to $45/bbl from $55/bbl and first half 2018 to $35/bbl from $55/bbl.
07/18/17
IMPC
07/18/17
INITIATION
Target $18
IMPC
Outperform
WPX Energy initiated with an Outperform at Imperial Capital
Imperial Capital analyst Irene Haas started WPX Energy with an Outperform rating and $18 price target.
06/22/17
COWN
06/22/17
UPGRADE
COWN
Outperform
WPX Energy upgraded to Outperform from Market Perform at Cowen
06/22/17
COWN
06/22/17
UPGRADE
Target $14
COWN
Outperform
WPX Energy upgraded to Outperform at Cowen
As reported previously, Cowen analyst Charles Robertson upgraded WPX Energy to Outperform from Market Perform citing the company's quality asset portfolio and strong management's forward thinking risk management. He believes the company will continue to grow and de-lever and its Northern Delaware and Bakken acreage provides a unique risk/reward. However, Robertson lowered his price target on WPX to $14 from $15.

TODAY'S FREE FLY STORIES

MSBI

Midland States

$33.03

-0.07 (-0.21%)

19:02
10/16/17
10/16
19:02
10/16/17
19:02
Hot Stocks
Midland States to acquire Alpine Bancorporation in roughly $181M deal »

Midland States Bancorp…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Oct

  • 15

    Nov

MYL

Mylan

$38.18

0.23 (0.61%)

, AGN

Allergan

$198.41

-7.11 (-3.46%)

18:46
10/16/17
10/16
18:46
10/16/17
18:46
Hot Stocks
Mylan CEO: 'Pleased' with court ruling on Allergan's Restasis patents »

Mylan (MYL) announced…

MYL

Mylan

$38.18

0.23 (0.61%)

AGN

Allergan

$198.41

-7.11 (-3.46%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 17

    Oct

  • 20

    Oct

  • 23

    Oct

  • 01

    Nov

  • 06

    Nov

  • 03

    Dec

NFLX

Netflix

$202.68

3.19 (1.60%)

18:44
10/16/17
10/16
18:44
10/16/17
18:44
Hot Stocks
Netflix says seeing steady growth, great success for streaming »

Says still has bias…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 16

    Oct

  • 22

    Oct

PCG

PG&E

$53.43

-4.29 (-7.43%)

18:42
10/16/17
10/16
18:42
10/16/17
18:42
Hot Stocks
PG&E sees restoring service to all electric customers in CA affected by fires »

PG&E said that more…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 02

    Nov

  • 05

    Nov

  • 05

    Nov

CYTR

CytRx

$0.38

-0.0142 (-3.64%)

18:29
10/16/17
10/16
18:29
10/16/17
18:29
Hot Stocks
CytRx granted listing extension pending results of stockholder vote »

CytRx 's request for…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 17

    Oct

EADSY

Airbus

$22.75

-0.07 (-0.31%)

, BDRBF

Bombardier

$1.88

0.03 (1.62%)

18:27
10/16/17
10/16
18:27
10/16/17
18:27
Hot Stocks
Airbus and Bombardier announce C Series partnership »

Airbus (EADSY) and…

EADSY

Airbus

$22.75

-0.07 (-0.31%)

BDRBF

Bombardier

$1.88

0.03 (1.62%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

IMDZ

Immune Design

$10.10

-0.85 (-7.76%)

18:16
10/16/17
10/16
18:16
10/16/17
18:16
Conference/Events
Immune Design to host conference call »

Conference call to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 17

    Oct

  • 08

    Nov

PG

Procter & Gamble

$93.14

0.1 (0.11%)

18:15
10/16/17
10/16
18:15
10/16/17
18:15
Hot Stocks
Trian: P&G board election results 'too close to call' »

Trian Fund Management,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Oct

AMZN

Amazon.com

$1,006.34

3.4 (0.34%)

18:14
10/16/17
10/16
18:14
10/16/17
18:14
Periodicals
NJ leaders offer up to $7B in tax incentives to lure Amazon to Newark, WSJ says »

New Jersey Governor Chris…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 16

    Oct

  • 16

    Oct

  • 17

    Oct

  • 22

    Oct

  • 26

    Oct

BDRBF

Bombardier

$1.88

0.03 (1.62%)

, EADSY

Airbus

$22.75

-0.07 (-0.31%)

18:09
10/16/17
10/16
18:09
10/16/17
18:09
Periodicals
Bombardier in talks with Airbus over CSeries jet unit JV, WSJ reports »

Bombardier (BDRBF) is in…

BDRBF

Bombardier

$1.88

0.03 (1.62%)

EADSY

Airbus

$22.75

-0.07 (-0.31%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

IPXL

Impax

$19.95

-0.85 (-4.09%)

17:55
10/16/17
10/16
17:55
10/16/17
17:55
Hot Stocks
Impax jumps 6% in after-hours after WSJ says Amneal deal near »

Shares of Impax are up…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 09

    Nov

IPXL

Impax

$19.95

-0.85 (-4.09%)

17:51
10/16/17
10/16
17:51
10/16/17
17:51
Periodicals
Impax and Amneal close to merger pact, WSJ says »

Impax Laboratories and…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 09

    Nov

AGII

Argo Group

$62.90

-0.25 (-0.40%)

17:36
10/16/17
10/16
17:36
10/16/17
17:36
Hot Stocks
Argo Group provides preliminary Q3 loss estimate »

Argo Group announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

FDEF

First Defiance Financial

$53.65

-0.25 (-0.46%)

17:34
10/16/17
10/16
17:34
10/16/17
17:34
Earnings
First Defiance Financial reports Q3 EPS 92c, consensus 89c »

Reports Q3 NII $ $25.0M,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 17

    Oct

BRO

Brown & Brown

$48.97

-0.42 (-0.85%)

17:33
10/16/17
10/16
17:33
10/16/17
17:33
Earnings
Brown & Brown reports Q3 EPS 53c, consensus 50c »

Reports Q3 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 17

    Oct

ORIG

Ocean Rig UDW

$26.18

0.51 (1.99%)

17:31
10/16/17
10/16
17:31
10/16/17
17:31
Hot Stocks
Ocean Rig holder BlueMountain intends to recommend company hire advisers »

Ocean Rig UDW holder…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

NFLX

Netflix

$202.68

3.19 (1.60%)

, IMDZ

Immune Design

$10.10

-0.85 (-7.76%)

17:31
10/16/17
10/16
17:31
10/16/17
17:31
Hot Stocks
On The Fly: After Hours Movers »

UP AFTER EARNINGS:…

NFLX

Netflix

$202.68

3.19 (1.60%)

IMDZ

Immune Design

$10.10

-0.85 (-7.76%)

SAVE

Spirit Airlines

$33.47

-0.33 (-0.98%)

UNH

UnitedHealth

$193.20

0.68 (0.35%)

BMI

Badger Meter

$50.80

-0.6 (-1.17%)

SONC

Sonic

$24.80

0.42 (1.72%)

ABEO

Abeona Therapeutics

$16.70

0.6 (3.73%)

VICL

Vical

$2.86

0.04 (1.42%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 16

    Oct

  • 16

    Oct

  • 17

    Oct

  • 17

    Oct

  • 17

    Oct

  • 22

    Oct

  • 23

    Oct

  • 08

    Nov

  • 17

    Oct

FDC

First Data

$18.01

0.39 (2.21%)

17:28
10/16/17
10/16
17:28
10/16/17
17:28
Hot Stocks
First Data CAO sells 3,996 common shares »

In a regulatory filing,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Oct

  • 30

    Oct

ROSG

Rosetta Genomics

$1.00

-0.0479 (-4.57%)

17:28
10/16/17
10/16
17:28
10/16/17
17:28
Syndicate
Breaking Syndicate news story on Rosetta Genomics »

Rosetta Genomics files to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

HRS

Harris

$135.90

-0.66 (-0.48%)

17:27
10/16/17
10/16
17:27
10/16/17
17:27
Hot Stocks
Harris awarded $100M government contract modification »

Harris Corp., Clifton,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

BA

Boeing

$259.75

-0.99 (-0.38%)

17:26
10/16/17
10/16
17:26
10/16/17
17:26
Hot Stocks
Boeing awarded $240.2M government contract »

The Boeing Co., Oklahoma…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Oct

PI

Impinj

$34.98

-0.71 (-1.99%)

17:22
10/16/17
10/16
17:22
10/16/17
17:22
Hot Stocks
Impinj COO sells 7,000 common shares »

In a regulatory filing,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 01

    Nov

  • 14

    Nov

  • 15

    Nov

ADOM

Adomani

$6.50

-0.36 (-5.25%)

17:21
10/16/17
10/16
17:21
10/16/17
17:21
Syndicate
Breaking Syndicate news story on Adomani »

Adomani files to sell…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SAVE

Spirit Airlines

$33.47

-0.33 (-0.98%)

17:20
10/16/17
10/16
17:20
10/16/17
17:20
Hot Stocks
Spirit Airlines raises Q3 total RASM view to (6.5%) from (8.5%)-(7%) »

Sees Q3 ASMs up 18%. Sees…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

RESN

Resonant

$4.38

-0.08 (-1.79%)

17:16
10/16/17
10/16
17:16
10/16/17
17:16
Hot Stocks
Breaking Hot Stocks news story on Resonant »

Longboard raises stake in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.